POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
Common stock to commence trading on the Nasdaq Capital Market on July 1, 2021 under the ticker symbol “PNT” Gross…
Pharmaceuticals, Biotechnology and Life Sciences
Common stock to commence trading on the Nasdaq Capital Market on July 1, 2021 under the ticker symbol “PNT” Gross…
NEW HAVEN, Conn. and MANCHESTER, United Kingdom, June 30, 2021 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (TSXV:BTI; OTCQB:BIOAF) (“Bioasis”) and…
Appointment of Chief Technical Operations Officer James Bircher continues evolution of leadership team to execute across near- and long-term priorities…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Company Has Now Received a Total of $750 million for Sale of Its True Human AntibodyAUSTIN, Texas, June 30, 2021…
HALIFAX, Nova Scotia, June 29, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results…
CAMBRIDGE, Mass., June 29, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on…
RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that…
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the “Company” or “Panbela”), a clinical stage biopharmaceutical…
PRINCETON, N.J., June 29, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced information regarding a key…